Iliac Stent Market Faces Challenges Due to Strict Regulatory Requirements and Availability of Alternative Treatments

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Iliac Stent Market- (Type (Self-expandable Stents, Balloon-expandable Stents and Others), By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesion and Complete Obstructive Lesions), By End-use (Hospitals, Outpatient Facilities and Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Iliac Stent Market is valued at US$ 1.02 Bn in 2023, and it is expected to reach US$ 1.61 Bn by 2031, with a CAGR of 6.07% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2416

An iliac stent is a small, steel-mesh implant designed for insertion into the iliac artery, a major pelvic artery responsible for supplying blood to the lower extremities. In patients with cardiovascular conditions, such as atherosclerosis, the primary objective of iliac stent placement is to alleviate arterial constriction or obstruction, thereby restoring proper blood flow.

The growing demand for iliac stents is driven by several key factors, including increased awareness of minimally invasive procedures, a rising prevalence of peripheral artery disease (PAD), and advancements in medical technology. Continuous innovation in stent design and materials has led to improved patient outcomes, further fueling market growth. Additionally, greater awareness among both patients and healthcare providers regarding the benefits of iliac stenting over alternative treatment options is contributing to its widespread adoption.

However, the market faces challenges such as stringent regulatory requirements and the availability of alternative therapies for cardiovascular conditions, which may hinder growth. Nevertheless, several factors are expected to drive market expansion, including an aging population prone to peripheral diseases, increased healthcare funding, a growing pool of skilled medical professionals, pharmaceutical companies seeking market expansion opportunities, and greater patient awareness of advanced treatment options.

List of Prominent Players in the Iliac Stent Market:
• BD
• Abbott
• Boston Scientific Corporation
• W. L. Gore & Associates, Inc.
• Medtronic
• Cook
• Terumo Corporation
• iVascular
• Getinge AB
• Biotronik SE & Co KG

Market Dynamics:
Drivers-
The global stent industry plays a pivotal role in driving the growth of the iliac stent market, supported by key factors such as the increasing demand for minimally invasive surgical procedures, technological advancements in medical devices, and the rising prevalence of cardiovascular diseases worldwide. These elements collectively serve as primary catalysts for market expansion.

Additionally, self-expandable stents account for a significant market share, as they have shown promising outcomes in the treatment of external iliac artery conditions. Furthermore, strategic initiatives by leading industry players, including new product development, regulatory approvals, and heightened awareness of peripheral artery diseases, are further accelerating market growth.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Challenges:
The growth of the iliac stent market faces several challenges, including the availability of alternative treatment options, stringent regulatory requirements, and complexities associated with angioplasty procedures. The presence of alternative cardiovascular treatments presents a substantial barrier, potentially discouraging both patients and healthcare providers from opting for stent implantation. Additionally, product recalls and challenges during stenting procedures may further hinder market expansion. Another key obstacle is the regulatory approval process, as stringent compliance requirements can delay the introduction of innovative stent technologies, thereby slowing market growth.

Regional Trends:
North America is expected to dominate the iliac stent market in terms of revenue share, with projections indicating a high CAGR in the coming years. This growth is driven by rising disease prevalence, increasing public awareness, strong government initiatives, rapid advancements in medical technology, and ongoing improvements in healthcare infrastructure. Furthermore, the presence of leading iliac stent manufacturers in the region, coupled with an aging population and a growing incidence of peripheral artery disease, continues to drive market demand, particularly in the United States.

Similarly, Europe holds a significant market share, supported by an increase in vascular procedures, advancements in medical technology, and government-led healthcare initiatives. The growing adoption of endovascular procedures is another key factor contributing to market expansion in the region.

Recent Developments:
• In January 2024, Abbott announced the launch of NavitorTM, their next-generation transcatheter aortic valve implantation (TAVI) system. This minimally invasive technology will now be accessible to patients in India who suffer from severe aortic stenosis and are deemed to be at high or extreme risk for surgery. The Navitor TAVI system is the newest offering from the company's extensive structural heart transcatheter portfolio, providing patients and doctors with less invasive alternatives for treating heart disorders.
• In February 2024, BD and the world's foremost manufacturer of laboratory automation technology, Hamilton, announced a partnership to create robotics-compatible reagent kits and automated applications that allow larger-scale single-cell multi-omics experiments to be conducted with more precision and less room for human error.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2416

Segmentation of Iliac Stent Market-
Iliac Stent Market-By Type
• Self-expandable Stents
• Balloon-expandable Stents
• Others
Iliac Stent Market-By Artery Lesions
• Common Iliac Artery Lesions
• Severe Calcified Lesions
• Complete Obstructive Lesions
Iliac Stent Market-By End-Use
• Hospitals
• Outpatient Facilities
• Others
Iliac Stent Market-By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.